SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Dec. 31, 2017

Schedule of Estimated Useful Lives of Property and Equipment

We generally provide for depreciation over the following estimated useful service lives.



	Years
Building	39
Leasehold improvements	Lesser of life or lease or expected useful life
Equipment and furniture	3 to 7
Vehicles	5
Computer software	3 to 5

Schedule of Property and Equipment

The following table summarizes the balances related to our property and equipment for 2017 and 2016 (amounts in millions):



	As of December 31,
	2017			2016
Building and leasehold improvements	7.8			6.9
Equipment and furniture	72.9			71.9
Computer software	97.2			96.8
	177.9			175.6
Less: accumulated depreciation	(146.8		)	(138.6		)
	$	31.1		$	37.0

Schedule of Financial Instruments Where Carrying Value and Fair Value Differ

The following details our financial instruments where the carrying value and the fair value differ (amounts in millions):



	Fair Value at Reporting Date Using
Financial Instrument	As of December 31, 2017		Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Long-term obligations	$	90.7	$	—	$	91.8	$	—

Schedule of Weighted-Average Shares Outstanding

The following table sets forth, for the periods indicated, shares used in our computation of the weighted-average shares outstanding, which are used to calculate our basic and diluted net income (loss) attributable to Amedisys, Inc. common stockholders (amounts in thousands):



	For the Years Ended December 31,
	2017	2016	2015
Weighted average number of shares outstanding – basic	33,704	33,198	33,018
Effect of dilutive securities:
Stock options	281	162	—
Non-vested stock and stock units	319	381	—
Weighted average number of shares outstanding – diluted	34,304	33,741	33,018
Anti-dilutive securities	271	221	922